SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-16-020799
Filing Date
2016-11-03
Accepted
2016-11-03 17:19:18
Documents
3
Period of Report
2016-11-03
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K aegr-earningsreleasex093016.htm 8-K 29702
2 EXHIBIT 99.1 earningsrelease110316.htm EX-99.1 227106
3 aegr2016b.jpg GRAPHIC 11181
  Complete submission text file 0001628280-16-020799.txt   273514
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34921 | Film No.: 161972788
SIC: 2834 Pharmaceutical Preparations